Global Pet Vaccine Market

Pet Vaccine Comprehensive Study by Type (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines), Mode of Administration (Injectable Vaccines, Intranasal Vaccines), Vaccination (Canine Family, Core Vaccines, Non-core Vaccines, Feline Family) Players and Region - Global Market Outlook to 2026

Pet Vaccine Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
According to The European Pet Food Industry, there are approximately 80 million European households who own at least one pet animal. People having animal pets as cats, dogs rabbit etc can have weakened immune systems so it is advisable to take extra precautions when choosing and handling pets. Animal vaccines help to control disease like rabies which can affect the pet holders hence the need for pet vaccines is propelling the Global PetVaccine Market. There are approximately 59000 people who die of rabies every year according to the Center for Disease Control. Parenteral animal rabies vaccines are administered under the supervision of the veterinarian. Pet vaccines account for 38% of the Global market with CAGR of 6.8% during 2018-2026. Some common dog pet vaccines include shots for canine distemper, measles, parvovirus, cav-2 for hepatitis, rabies, parainfluenza, bordetella, leptospirosis, lyme, coronavirus and giardia. Few Feline pet vaccines are available to prevent conditions including feline rhinotracheitis, feline calicivirus, feline distemper, feline panleukopenia, feline leukemia virus, feline immunodeficiency virus and feline infectious peritonitis and Chlamydia. Moreover, Not all cats need all the pet vaccinations and what they need will also vary on their age.
This growth is primarily driven by Growing adoption rate of pets among pet owners, Increasing community awareness regarding health of pets and The Government initiatives creating awareness about pet vaccines..

Globally, a noticeable market trend is evident Increased prevalence of disease like rabies among pet animals and the probability of transmission of this disease to the pet holders . The Pharmaceuticals sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Zoetis (United States), Merck Sharp & Dohme Corp. (United States), Bayer AG (Germany), Elanco US Inc. (United States), Merial Inc. (United Kingdom), Virbac (France), Phibro Animal Health Corp. (United States), Boehringr Ingelheim GmbH (Germany), Tianjin Ringpu Bio-Technology Co., Ltd (China), Ceva (United States), Vetoquinol (France), Diamond Animal Healthcare (United States), India Immunological Ltd. (India), Sanofi S.A. (France), PHL Associates, Inc. (United States), Hygieia Biological Laboratories (United States), Colorado Serum Company (United States), Arko Laboratories, Ltd. (United States) and Intervacc AB (Sweden) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In July 2018, Intervacc, a Swedish company recieves funding from Eurostar-2 program for further development of vaccine for piglets. This vaccine is based on recombinant proteins to meet the increasing need for effective vaccines in animal health care, with a very good safety profile.

Market Drivers
  • Growing adoption rate of pets among pet owners
  • Increasing community awareness regarding health of pets
  • The Government initiatives creating awareness about pet vaccines.

Market Trend
  • Increased prevalence of disease like rabies among pet animals and the probability of transmission of this disease to the pet holders
  • Increasing ownership of pets and great demand for dairy products.

Restraints
  • Rising maintenance cost for vaccine storage
  • Lack of awareness about pet vaccines among pet holders in underdeveloped countries and its need for the administration to the pets are hampering the market.

Opportunities
Technological advancement is fueling the entry of novel veterinary vaccines are providing an opportunity for the market.
Challenges
Strict government regulations impacting the Global pet vaccine market is posing a challenge for this market.

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Pet Vaccine Study Sheds Light on
— The Pet Vaccine Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Pet Vaccine industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Pet Vaccine industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
By Mode of Administration
  • Injectable Vaccines
  • Intranasal Vaccines

By Vaccination
  • Canine Family
  • Core Vaccines
  • Non-core Vaccines
  • Feline Family

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing adoption rate of pets among pet owners
      • 3.2.2. Increasing community awareness regarding health of pets
      • 3.2.3. The Government initiatives creating awareness about pet vaccines.
    • 3.3. Market Challenges
      • 3.3.1. Strict government regulations impacting the Global pet vaccine market is posing a challenge for this market.
    • 3.4. Market Trends
      • 3.4.1. Increased prevalence of disease like rabies among pet animals and the probability of transmission of this disease to the pet holders
      • 3.4.2. Increasing ownership of pets and great demand for dairy products.
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pet Vaccine, by Type, Mode of Administration, Vaccination and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Pet Vaccine (Value)
      • 5.2.1. Global Pet Vaccine by: Type (Value)
        • 5.2.1.1. Attenuated Live Vaccines
        • 5.2.1.2. Conjugate Vaccines
        • 5.2.1.3. Inactivated Vaccines
        • 5.2.1.4. Subunit Vaccines
        • 5.2.1.5. Toxoid Vaccines
        • 5.2.1.6. DNA Vaccines
        • 5.2.1.7. Recombinant Vaccines
      • 5.2.2. Global Pet Vaccine by: Mode of Administration (Value)
        • 5.2.2.1. Injectable Vaccines
        • 5.2.2.2. Intranasal Vaccines
      • 5.2.3. Global Pet Vaccine by: Vaccination (Value)
        • 5.2.3.1. Canine Family
        • 5.2.3.2. Core Vaccines
        • 5.2.3.3. Non-core Vaccines
        • 5.2.3.4. Feline Family
      • 5.2.4. Global Pet Vaccine Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Pet Vaccine (Volume)
      • 5.3.1. Global Pet Vaccine by: Type (Volume)
        • 5.3.1.1. Attenuated Live Vaccines
        • 5.3.1.2. Conjugate Vaccines
        • 5.3.1.3. Inactivated Vaccines
        • 5.3.1.4. Subunit Vaccines
        • 5.3.1.5. Toxoid Vaccines
        • 5.3.1.6. DNA Vaccines
        • 5.3.1.7. Recombinant Vaccines
      • 5.3.2. Global Pet Vaccine by: Mode of Administration (Volume)
        • 5.3.2.1. Injectable Vaccines
        • 5.3.2.2. Intranasal Vaccines
      • 5.3.3. Global Pet Vaccine by: Vaccination (Volume)
        • 5.3.3.1. Canine Family
        • 5.3.3.2. Core Vaccines
        • 5.3.3.3. Non-core Vaccines
        • 5.3.3.4. Feline Family
      • 5.3.4. Global Pet Vaccine Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Pet Vaccine (Price)
      • 5.4.1. Global Pet Vaccine by: Type (Price)
  • 6. Pet Vaccine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Zoetis (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck Sharp & Dohme Corp. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bayer AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Elanco US Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Merial Inc. (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Virbac (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Phibro Animal Health Corp. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Boehringr Ingelheim GmbH (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Tianjin Ringpu Bio-Technology Co., Ltd (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Ceva (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Vetoquinol (France)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Diamond Animal Healthcare (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. India Immunological Ltd. (India)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Sanofi S.A. (France)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. PHL Associates, Inc. (United States)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. Hygieia Biological Laboratories (United States)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
      • 6.4.17. Colorado Serum Company (United States)
        • 6.4.17.1. Business Overview
        • 6.4.17.2. Products/Services Offerings
        • 6.4.17.3. Financial Analysis
        • 6.4.17.4. SWOT Analysis
      • 6.4.18. Arko Laboratories, Ltd. (United States)
        • 6.4.18.1. Business Overview
        • 6.4.18.2. Products/Services Offerings
        • 6.4.18.3. Financial Analysis
        • 6.4.18.4. SWOT Analysis
      • 6.4.19. Intervacc AB (Sweden)
        • 6.4.19.1. Business Overview
        • 6.4.19.2. Products/Services Offerings
        • 6.4.19.3. Financial Analysis
        • 6.4.19.4. SWOT Analysis
  • 7. Global Pet Vaccine Sale, by Type, Mode of Administration, Vaccination and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Pet Vaccine (Value)
      • 7.2.1. Global Pet Vaccine by: Type (Value)
        • 7.2.1.1. Attenuated Live Vaccines
        • 7.2.1.2. Conjugate Vaccines
        • 7.2.1.3. Inactivated Vaccines
        • 7.2.1.4. Subunit Vaccines
        • 7.2.1.5. Toxoid Vaccines
        • 7.2.1.6. DNA Vaccines
        • 7.2.1.7. Recombinant Vaccines
      • 7.2.2. Global Pet Vaccine by: Mode of Administration (Value)
        • 7.2.2.1. Injectable Vaccines
        • 7.2.2.2. Intranasal Vaccines
      • 7.2.3. Global Pet Vaccine by: Vaccination (Value)
        • 7.2.3.1. Canine Family
        • 7.2.3.2. Core Vaccines
        • 7.2.3.3. Non-core Vaccines
        • 7.2.3.4. Feline Family
      • 7.2.4. Global Pet Vaccine Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Pet Vaccine (Volume)
      • 7.3.1. Global Pet Vaccine by: Type (Volume)
        • 7.3.1.1. Attenuated Live Vaccines
        • 7.3.1.2. Conjugate Vaccines
        • 7.3.1.3. Inactivated Vaccines
        • 7.3.1.4. Subunit Vaccines
        • 7.3.1.5. Toxoid Vaccines
        • 7.3.1.6. DNA Vaccines
        • 7.3.1.7. Recombinant Vaccines
      • 7.3.2. Global Pet Vaccine by: Mode of Administration (Volume)
        • 7.3.2.1. Injectable Vaccines
        • 7.3.2.2. Intranasal Vaccines
      • 7.3.3. Global Pet Vaccine by: Vaccination (Volume)
        • 7.3.3.1. Canine Family
        • 7.3.3.2. Core Vaccines
        • 7.3.3.3. Non-core Vaccines
        • 7.3.3.4. Feline Family
      • 7.3.4. Global Pet Vaccine Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Pet Vaccine (Price)
      • 7.4.1. Global Pet Vaccine by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pet Vaccine: by Type(USD Million)
  • Table 2. Pet Vaccine Attenuated Live Vaccines , by Region USD Million (2015-2020)
  • Table 3. Pet Vaccine Conjugate Vaccines , by Region USD Million (2015-2020)
  • Table 4. Pet Vaccine Inactivated Vaccines , by Region USD Million (2015-2020)
  • Table 5. Pet Vaccine Subunit Vaccines , by Region USD Million (2015-2020)
  • Table 6. Pet Vaccine Toxoid Vaccines , by Region USD Million (2015-2020)
  • Table 7. Pet Vaccine DNA Vaccines , by Region USD Million (2015-2020)
  • Table 8. Pet Vaccine Recombinant Vaccines , by Region USD Million (2015-2020)
  • Table 9. Pet Vaccine: by Mode of Administration(USD Million)
  • Table 10. Pet Vaccine Injectable Vaccines , by Region USD Million (2015-2020)
  • Table 11. Pet Vaccine Intranasal Vaccines , by Region USD Million (2015-2020)
  • Table 12. Pet Vaccine: by Vaccination(USD Million)
  • Table 13. Pet Vaccine Canine Family , by Region USD Million (2015-2020)
  • Table 14. Pet Vaccine Core Vaccines , by Region USD Million (2015-2020)
  • Table 15. Pet Vaccine Non-core Vaccines , by Region USD Million (2015-2020)
  • Table 16. Pet Vaccine Feline Family , by Region USD Million (2015-2020)
  • Table 17. South America Pet Vaccine, by Country USD Million (2015-2020)
  • Table 18. South America Pet Vaccine, by Type USD Million (2015-2020)
  • Table 19. South America Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 20. South America Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 21. Brazil Pet Vaccine, by Type USD Million (2015-2020)
  • Table 22. Brazil Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 23. Brazil Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 24. Argentina Pet Vaccine, by Type USD Million (2015-2020)
  • Table 25. Argentina Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 26. Argentina Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 27. Rest of South America Pet Vaccine, by Type USD Million (2015-2020)
  • Table 28. Rest of South America Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 29. Rest of South America Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 30. Asia Pacific Pet Vaccine, by Country USD Million (2015-2020)
  • Table 31. Asia Pacific Pet Vaccine, by Type USD Million (2015-2020)
  • Table 32. Asia Pacific Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 33. Asia Pacific Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 34. China Pet Vaccine, by Type USD Million (2015-2020)
  • Table 35. China Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 36. China Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 37. Japan Pet Vaccine, by Type USD Million (2015-2020)
  • Table 38. Japan Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 39. Japan Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 40. India Pet Vaccine, by Type USD Million (2015-2020)
  • Table 41. India Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 42. India Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 43. South Korea Pet Vaccine, by Type USD Million (2015-2020)
  • Table 44. South Korea Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 45. South Korea Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 46. Taiwan Pet Vaccine, by Type USD Million (2015-2020)
  • Table 47. Taiwan Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 48. Taiwan Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 49. Australia Pet Vaccine, by Type USD Million (2015-2020)
  • Table 50. Australia Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 51. Australia Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 52. Rest of Asia-Pacific Pet Vaccine, by Type USD Million (2015-2020)
  • Table 53. Rest of Asia-Pacific Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 54. Rest of Asia-Pacific Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 55. Europe Pet Vaccine, by Country USD Million (2015-2020)
  • Table 56. Europe Pet Vaccine, by Type USD Million (2015-2020)
  • Table 57. Europe Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 58. Europe Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 59. Germany Pet Vaccine, by Type USD Million (2015-2020)
  • Table 60. Germany Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 61. Germany Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 62. France Pet Vaccine, by Type USD Million (2015-2020)
  • Table 63. France Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 64. France Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 65. Italy Pet Vaccine, by Type USD Million (2015-2020)
  • Table 66. Italy Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 67. Italy Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 68. United Kingdom Pet Vaccine, by Type USD Million (2015-2020)
  • Table 69. United Kingdom Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 70. United Kingdom Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 71. Netherlands Pet Vaccine, by Type USD Million (2015-2020)
  • Table 72. Netherlands Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 73. Netherlands Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 74. Rest of Europe Pet Vaccine, by Type USD Million (2015-2020)
  • Table 75. Rest of Europe Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 76. Rest of Europe Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 77. MEA Pet Vaccine, by Country USD Million (2015-2020)
  • Table 78. MEA Pet Vaccine, by Type USD Million (2015-2020)
  • Table 79. MEA Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 80. MEA Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 81. Middle East Pet Vaccine, by Type USD Million (2015-2020)
  • Table 82. Middle East Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 83. Middle East Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 84. Africa Pet Vaccine, by Type USD Million (2015-2020)
  • Table 85. Africa Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 86. Africa Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 87. North America Pet Vaccine, by Country USD Million (2015-2020)
  • Table 88. North America Pet Vaccine, by Type USD Million (2015-2020)
  • Table 89. North America Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 90. North America Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 91. United States Pet Vaccine, by Type USD Million (2015-2020)
  • Table 92. United States Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 93. United States Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 94. Canada Pet Vaccine, by Type USD Million (2015-2020)
  • Table 95. Canada Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 96. Canada Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 97. Mexico Pet Vaccine, by Type USD Million (2015-2020)
  • Table 98. Mexico Pet Vaccine, by Mode of Administration USD Million (2015-2020)
  • Table 99. Mexico Pet Vaccine, by Vaccination USD Million (2015-2020)
  • Table 100. Pet Vaccine Sales: by Type(K Tonnes)
  • Table 101. Pet Vaccine Sales Attenuated Live Vaccines , by Region K Tonnes (2015-2020)
  • Table 102. Pet Vaccine Sales Conjugate Vaccines , by Region K Tonnes (2015-2020)
  • Table 103. Pet Vaccine Sales Inactivated Vaccines , by Region K Tonnes (2015-2020)
  • Table 104. Pet Vaccine Sales Subunit Vaccines , by Region K Tonnes (2015-2020)
  • Table 105. Pet Vaccine Sales Toxoid Vaccines , by Region K Tonnes (2015-2020)
  • Table 106. Pet Vaccine Sales DNA Vaccines , by Region K Tonnes (2015-2020)
  • Table 107. Pet Vaccine Sales Recombinant Vaccines , by Region K Tonnes (2015-2020)
  • Table 108. Pet Vaccine Sales: by Mode of Administration(K Tonnes)
  • Table 109. Pet Vaccine Sales Injectable Vaccines , by Region K Tonnes (2015-2020)
  • Table 110. Pet Vaccine Sales Intranasal Vaccines , by Region K Tonnes (2015-2020)
  • Table 111. Pet Vaccine Sales: by Vaccination(K Tonnes)
  • Table 112. Pet Vaccine Sales Canine Family , by Region K Tonnes (2015-2020)
  • Table 113. Pet Vaccine Sales Core Vaccines , by Region K Tonnes (2015-2020)
  • Table 114. Pet Vaccine Sales Non-core Vaccines , by Region K Tonnes (2015-2020)
  • Table 115. Pet Vaccine Sales Feline Family , by Region K Tonnes (2015-2020)
  • Table 116. South America Pet Vaccine Sales, by Country K Tonnes (2015-2020)
  • Table 117. South America Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 118. South America Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 119. South America Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 120. Brazil Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 121. Brazil Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 122. Brazil Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 123. Argentina Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 124. Argentina Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 125. Argentina Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 126. Rest of South America Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 127. Rest of South America Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 128. Rest of South America Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 129. Asia Pacific Pet Vaccine Sales, by Country K Tonnes (2015-2020)
  • Table 130. Asia Pacific Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 131. Asia Pacific Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 132. Asia Pacific Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 133. China Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 134. China Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 135. China Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 136. Japan Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 137. Japan Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 138. Japan Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 139. India Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 140. India Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 141. India Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 142. South Korea Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 143. South Korea Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 144. South Korea Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 145. Taiwan Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 146. Taiwan Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 147. Taiwan Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 148. Australia Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 149. Australia Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 150. Australia Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 151. Rest of Asia-Pacific Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 152. Rest of Asia-Pacific Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 153. Rest of Asia-Pacific Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 154. Europe Pet Vaccine Sales, by Country K Tonnes (2015-2020)
  • Table 155. Europe Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 156. Europe Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 157. Europe Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 158. Germany Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 159. Germany Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 160. Germany Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 161. France Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 162. France Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 163. France Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 164. Italy Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 165. Italy Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 166. Italy Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 167. United Kingdom Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 168. United Kingdom Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 169. United Kingdom Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 170. Netherlands Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 171. Netherlands Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 172. Netherlands Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 173. Rest of Europe Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 174. Rest of Europe Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 175. Rest of Europe Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 176. MEA Pet Vaccine Sales, by Country K Tonnes (2015-2020)
  • Table 177. MEA Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 178. MEA Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 179. MEA Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 180. Middle East Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 181. Middle East Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 182. Middle East Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 183. Africa Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 184. Africa Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 185. Africa Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 186. North America Pet Vaccine Sales, by Country K Tonnes (2015-2020)
  • Table 187. North America Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 188. North America Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 189. North America Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 190. United States Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 191. United States Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 192. United States Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 193. Canada Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 194. Canada Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 195. Canada Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 196. Mexico Pet Vaccine Sales, by Type K Tonnes (2015-2020)
  • Table 197. Mexico Pet Vaccine Sales, by Mode of Administration K Tonnes (2015-2020)
  • Table 198. Mexico Pet Vaccine Sales, by Vaccination K Tonnes (2015-2020)
  • Table 199. Pet Vaccine: by Type(USD/Units)
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Company Basic Information, Sales Area and Its Competitors
  • Table 212. Company Basic Information, Sales Area and Its Competitors
  • Table 213. Company Basic Information, Sales Area and Its Competitors
  • Table 214. Company Basic Information, Sales Area and Its Competitors
  • Table 215. Company Basic Information, Sales Area and Its Competitors
  • Table 216. Company Basic Information, Sales Area and Its Competitors
  • Table 217. Company Basic Information, Sales Area and Its Competitors
  • Table 218. Company Basic Information, Sales Area and Its Competitors
  • Table 219. Pet Vaccine: by Type(USD Million)
  • Table 220. Pet Vaccine Attenuated Live Vaccines , by Region USD Million (2021-2026)
  • Table 221. Pet Vaccine Conjugate Vaccines , by Region USD Million (2021-2026)
  • Table 222. Pet Vaccine Inactivated Vaccines , by Region USD Million (2021-2026)
  • Table 223. Pet Vaccine Subunit Vaccines , by Region USD Million (2021-2026)
  • Table 224. Pet Vaccine Toxoid Vaccines , by Region USD Million (2021-2026)
  • Table 225. Pet Vaccine DNA Vaccines , by Region USD Million (2021-2026)
  • Table 226. Pet Vaccine Recombinant Vaccines , by Region USD Million (2021-2026)
  • Table 227. Pet Vaccine: by Mode of Administration(USD Million)
  • Table 228. Pet Vaccine Injectable Vaccines , by Region USD Million (2021-2026)
  • Table 229. Pet Vaccine Intranasal Vaccines , by Region USD Million (2021-2026)
  • Table 230. Pet Vaccine: by Vaccination(USD Million)
  • Table 231. Pet Vaccine Canine Family , by Region USD Million (2021-2026)
  • Table 232. Pet Vaccine Core Vaccines , by Region USD Million (2021-2026)
  • Table 233. Pet Vaccine Non-core Vaccines , by Region USD Million (2021-2026)
  • Table 234. Pet Vaccine Feline Family , by Region USD Million (2021-2026)
  • Table 235. South America Pet Vaccine, by Country USD Million (2021-2026)
  • Table 236. South America Pet Vaccine, by Type USD Million (2021-2026)
  • Table 237. South America Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 238. South America Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 239. Brazil Pet Vaccine, by Type USD Million (2021-2026)
  • Table 240. Brazil Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 241. Brazil Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 242. Argentina Pet Vaccine, by Type USD Million (2021-2026)
  • Table 243. Argentina Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 244. Argentina Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 245. Rest of South America Pet Vaccine, by Type USD Million (2021-2026)
  • Table 246. Rest of South America Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 247. Rest of South America Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 248. Asia Pacific Pet Vaccine, by Country USD Million (2021-2026)
  • Table 249. Asia Pacific Pet Vaccine, by Type USD Million (2021-2026)
  • Table 250. Asia Pacific Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 251. Asia Pacific Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 252. China Pet Vaccine, by Type USD Million (2021-2026)
  • Table 253. China Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 254. China Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 255. Japan Pet Vaccine, by Type USD Million (2021-2026)
  • Table 256. Japan Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 257. Japan Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 258. India Pet Vaccine, by Type USD Million (2021-2026)
  • Table 259. India Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 260. India Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 261. South Korea Pet Vaccine, by Type USD Million (2021-2026)
  • Table 262. South Korea Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 263. South Korea Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 264. Taiwan Pet Vaccine, by Type USD Million (2021-2026)
  • Table 265. Taiwan Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 266. Taiwan Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 267. Australia Pet Vaccine, by Type USD Million (2021-2026)
  • Table 268. Australia Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 269. Australia Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 270. Rest of Asia-Pacific Pet Vaccine, by Type USD Million (2021-2026)
  • Table 271. Rest of Asia-Pacific Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 272. Rest of Asia-Pacific Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 273. Europe Pet Vaccine, by Country USD Million (2021-2026)
  • Table 274. Europe Pet Vaccine, by Type USD Million (2021-2026)
  • Table 275. Europe Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 276. Europe Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 277. Germany Pet Vaccine, by Type USD Million (2021-2026)
  • Table 278. Germany Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 279. Germany Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 280. France Pet Vaccine, by Type USD Million (2021-2026)
  • Table 281. France Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 282. France Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 283. Italy Pet Vaccine, by Type USD Million (2021-2026)
  • Table 284. Italy Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 285. Italy Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 286. United Kingdom Pet Vaccine, by Type USD Million (2021-2026)
  • Table 287. United Kingdom Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 288. United Kingdom Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 289. Netherlands Pet Vaccine, by Type USD Million (2021-2026)
  • Table 290. Netherlands Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 291. Netherlands Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 292. Rest of Europe Pet Vaccine, by Type USD Million (2021-2026)
  • Table 293. Rest of Europe Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 294. Rest of Europe Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 295. MEA Pet Vaccine, by Country USD Million (2021-2026)
  • Table 296. MEA Pet Vaccine, by Type USD Million (2021-2026)
  • Table 297. MEA Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 298. MEA Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 299. Middle East Pet Vaccine, by Type USD Million (2021-2026)
  • Table 300. Middle East Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 301. Middle East Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 302. Africa Pet Vaccine, by Type USD Million (2021-2026)
  • Table 303. Africa Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 304. Africa Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 305. North America Pet Vaccine, by Country USD Million (2021-2026)
  • Table 306. North America Pet Vaccine, by Type USD Million (2021-2026)
  • Table 307. North America Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 308. North America Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 309. United States Pet Vaccine, by Type USD Million (2021-2026)
  • Table 310. United States Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 311. United States Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 312. Canada Pet Vaccine, by Type USD Million (2021-2026)
  • Table 313. Canada Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 314. Canada Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 315. Mexico Pet Vaccine, by Type USD Million (2021-2026)
  • Table 316. Mexico Pet Vaccine, by Mode of Administration USD Million (2021-2026)
  • Table 317. Mexico Pet Vaccine, by Vaccination USD Million (2021-2026)
  • Table 318. Pet Vaccine Sales: by Type(K Tonnes)
  • Table 319. Pet Vaccine Sales Attenuated Live Vaccines , by Region K Tonnes (2021-2026)
  • Table 320. Pet Vaccine Sales Conjugate Vaccines , by Region K Tonnes (2021-2026)
  • Table 321. Pet Vaccine Sales Inactivated Vaccines , by Region K Tonnes (2021-2026)
  • Table 322. Pet Vaccine Sales Subunit Vaccines , by Region K Tonnes (2021-2026)
  • Table 323. Pet Vaccine Sales Toxoid Vaccines , by Region K Tonnes (2021-2026)
  • Table 324. Pet Vaccine Sales DNA Vaccines , by Region K Tonnes (2021-2026)
  • Table 325. Pet Vaccine Sales Recombinant Vaccines , by Region K Tonnes (2021-2026)
  • Table 326. Pet Vaccine Sales: by Mode of Administration(K Tonnes)
  • Table 327. Pet Vaccine Sales Injectable Vaccines , by Region K Tonnes (2021-2026)
  • Table 328. Pet Vaccine Sales Intranasal Vaccines , by Region K Tonnes (2021-2026)
  • Table 329. Pet Vaccine Sales: by Vaccination(K Tonnes)
  • Table 330. Pet Vaccine Sales Canine Family , by Region K Tonnes (2021-2026)
  • Table 331. Pet Vaccine Sales Core Vaccines , by Region K Tonnes (2021-2026)
  • Table 332. Pet Vaccine Sales Non-core Vaccines , by Region K Tonnes (2021-2026)
  • Table 333. Pet Vaccine Sales Feline Family , by Region K Tonnes (2021-2026)
  • Table 334. South America Pet Vaccine Sales, by Country K Tonnes (2021-2026)
  • Table 335. South America Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 336. South America Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 337. South America Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 338. Brazil Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 339. Brazil Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 340. Brazil Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 341. Argentina Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 342. Argentina Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 343. Argentina Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 344. Rest of South America Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 345. Rest of South America Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 346. Rest of South America Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 347. Asia Pacific Pet Vaccine Sales, by Country K Tonnes (2021-2026)
  • Table 348. Asia Pacific Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 349. Asia Pacific Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 350. Asia Pacific Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 351. China Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 352. China Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 353. China Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 354. Japan Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 355. Japan Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 356. Japan Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 357. India Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 358. India Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 359. India Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 360. South Korea Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 361. South Korea Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 362. South Korea Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 363. Taiwan Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 364. Taiwan Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 365. Taiwan Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 366. Australia Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 367. Australia Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 368. Australia Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 369. Rest of Asia-Pacific Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 370. Rest of Asia-Pacific Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 371. Rest of Asia-Pacific Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 372. Europe Pet Vaccine Sales, by Country K Tonnes (2021-2026)
  • Table 373. Europe Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 374. Europe Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 375. Europe Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 376. Germany Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 377. Germany Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 378. Germany Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 379. France Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 380. France Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 381. France Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 382. Italy Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 383. Italy Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 384. Italy Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 385. United Kingdom Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 386. United Kingdom Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 387. United Kingdom Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 388. Netherlands Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 389. Netherlands Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 390. Netherlands Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 391. Rest of Europe Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 392. Rest of Europe Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 393. Rest of Europe Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 394. MEA Pet Vaccine Sales, by Country K Tonnes (2021-2026)
  • Table 395. MEA Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 396. MEA Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 397. MEA Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 398. Middle East Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 399. Middle East Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 400. Middle East Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 401. Africa Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 402. Africa Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 403. Africa Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 404. North America Pet Vaccine Sales, by Country K Tonnes (2021-2026)
  • Table 405. North America Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 406. North America Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 407. North America Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 408. United States Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 409. United States Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 410. United States Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 411. Canada Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 412. Canada Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 413. Canada Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 414. Mexico Pet Vaccine Sales, by Type K Tonnes (2021-2026)
  • Table 415. Mexico Pet Vaccine Sales, by Mode of Administration K Tonnes (2021-2026)
  • Table 416. Mexico Pet Vaccine Sales, by Vaccination K Tonnes (2021-2026)
  • Table 417. Pet Vaccine: by Type(USD/Units)
  • Table 418. Research Programs/Design for This Report
  • Table 419. Key Data Information from Secondary Sources
  • Table 420. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pet Vaccine: by Type USD Million (2015-2020)
  • Figure 5. Global Pet Vaccine: by Mode of Administration USD Million (2015-2020)
  • Figure 6. Global Pet Vaccine: by Vaccination USD Million (2015-2020)
  • Figure 7. South America Pet Vaccine Share (%), by Country
  • Figure 8. Asia Pacific Pet Vaccine Share (%), by Country
  • Figure 9. Europe Pet Vaccine Share (%), by Country
  • Figure 10. MEA Pet Vaccine Share (%), by Country
  • Figure 11. North America Pet Vaccine Share (%), by Country
  • Figure 12. Global Pet Vaccine: by Type K Tonnes (2015-2020)
  • Figure 13. Global Pet Vaccine: by Mode of Administration K Tonnes (2015-2020)
  • Figure 14. Global Pet Vaccine: by Vaccination K Tonnes (2015-2020)
  • Figure 15. South America Pet Vaccine Share (%), by Country
  • Figure 16. Asia Pacific Pet Vaccine Share (%), by Country
  • Figure 17. Europe Pet Vaccine Share (%), by Country
  • Figure 18. MEA Pet Vaccine Share (%), by Country
  • Figure 19. North America Pet Vaccine Share (%), by Country
  • Figure 20. Global Pet Vaccine: by Type USD/Units (2015-2020)
  • Figure 21. Global Pet Vaccine share by Players 2020 (%)
  • Figure 22. Global Pet Vaccine share by Players (Top 3) 2020(%)
  • Figure 23. Global Pet Vaccine share by Players (Top 5) 2020(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Zoetis (United States) Revenue, Net Income and Gross profit
  • Figure 26. Zoetis (United States) Revenue: by Geography 2020
  • Figure 27. Merck Sharp & Dohme Corp. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Merck Sharp & Dohme Corp. (United States) Revenue: by Geography 2020
  • Figure 29. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 30. Bayer AG (Germany) Revenue: by Geography 2020
  • Figure 31. Elanco US Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Elanco US Inc. (United States) Revenue: by Geography 2020
  • Figure 33. Merial Inc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. Merial Inc. (United Kingdom) Revenue: by Geography 2020
  • Figure 35. Virbac (France) Revenue, Net Income and Gross profit
  • Figure 36. Virbac (France) Revenue: by Geography 2020
  • Figure 37. Phibro Animal Health Corp. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Phibro Animal Health Corp. (United States) Revenue: by Geography 2020
  • Figure 39. Boehringr Ingelheim GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 40. Boehringr Ingelheim GmbH (Germany) Revenue: by Geography 2020
  • Figure 41. Tianjin Ringpu Bio-Technology Co., Ltd (China) Revenue, Net Income and Gross profit
  • Figure 42. Tianjin Ringpu Bio-Technology Co., Ltd (China) Revenue: by Geography 2020
  • Figure 43. Ceva (United States) Revenue, Net Income and Gross profit
  • Figure 44. Ceva (United States) Revenue: by Geography 2020
  • Figure 45. Vetoquinol (France) Revenue, Net Income and Gross profit
  • Figure 46. Vetoquinol (France) Revenue: by Geography 2020
  • Figure 47. Diamond Animal Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 48. Diamond Animal Healthcare (United States) Revenue: by Geography 2020
  • Figure 49. India Immunological Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 50. India Immunological Ltd. (India) Revenue: by Geography 2020
  • Figure 51. Sanofi S.A. (France) Revenue, Net Income and Gross profit
  • Figure 52. Sanofi S.A. (France) Revenue: by Geography 2020
  • Figure 53. PHL Associates, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 54. PHL Associates, Inc. (United States) Revenue: by Geography 2020
  • Figure 55. Hygieia Biological Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 56. Hygieia Biological Laboratories (United States) Revenue: by Geography 2020
  • Figure 57. Colorado Serum Company (United States) Revenue, Net Income and Gross profit
  • Figure 58. Colorado Serum Company (United States) Revenue: by Geography 2020
  • Figure 59. Arko Laboratories, Ltd. (United States) Revenue, Net Income and Gross profit
  • Figure 60. Arko Laboratories, Ltd. (United States) Revenue: by Geography 2020
  • Figure 61. Intervacc AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 62. Intervacc AB (Sweden) Revenue: by Geography 2020
  • Figure 63. Global Pet Vaccine: by Type USD Million (2021-2026)
  • Figure 64. Global Pet Vaccine: by Mode of Administration USD Million (2021-2026)
  • Figure 65. Global Pet Vaccine: by Vaccination USD Million (2021-2026)
  • Figure 66. South America Pet Vaccine Share (%), by Country
  • Figure 67. Asia Pacific Pet Vaccine Share (%), by Country
  • Figure 68. Europe Pet Vaccine Share (%), by Country
  • Figure 69. MEA Pet Vaccine Share (%), by Country
  • Figure 70. North America Pet Vaccine Share (%), by Country
  • Figure 71. Global Pet Vaccine: by Type K Tonnes (2021-2026)
  • Figure 72. Global Pet Vaccine: by Mode of Administration K Tonnes (2021-2026)
  • Figure 73. Global Pet Vaccine: by Vaccination K Tonnes (2021-2026)
  • Figure 74. South America Pet Vaccine Share (%), by Country
  • Figure 75. Asia Pacific Pet Vaccine Share (%), by Country
  • Figure 76. Europe Pet Vaccine Share (%), by Country
  • Figure 77. MEA Pet Vaccine Share (%), by Country
  • Figure 78. North America Pet Vaccine Share (%), by Country
  • Figure 79. Global Pet Vaccine: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Zoetis (United States)
  • Merck Sharp & Dohme Corp. (United States)
  • Bayer AG (Germany)
  • Elanco US Inc. (United States)
  • Merial Inc. (United Kingdom)
  • Virbac (France)
  • Phibro Animal Health Corp. (United States)
  • Boehringr Ingelheim GmbH (Germany)
  • Tianjin Ringpu Bio-Technology Co., Ltd (China)
  • Ceva (United States)
  • Vetoquinol (France)
  • Diamond Animal Healthcare (United States)
  • India Immunological Ltd. (India)
  • Sanofi S.A. (France)
  • PHL Associates, Inc. (United States)
  • Hygieia Biological Laboratories (United States)
  • Colorado Serum Company (United States)
  • Arko Laboratories, Ltd. (United States)
  • Intervacc AB (Sweden)
Additional players considered in the study are as follows:
Vaxxinova International B V (Netherlands) , Merial (United States) , Anicon Labor GmbH (Germany) , Nexvet (Australia)
Select User Access Type

Key Highlights of Report


Oct 2021 245 Pages 97 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Pet Vaccine Market Quantitative research analysis
Global Pet Vaccine Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Pet Vaccine market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Pet Vaccine market are Zoetis (United States), Merck Sharp & Dohme Corp. (United States), Bayer AG (Germany), Elanco US Inc. (United States), Merial Inc. (United Kingdom), Virbac (France), Phibro Animal Health Corp. (United States), Boehringr Ingelheim GmbH (Germany), Tianjin Ringpu Bio-Technology Co., Ltd (China), Ceva (United States), Vetoquinol (France), Diamond Animal Healthcare (United States), India Immunological Ltd. (India), Sanofi S.A. (France), PHL Associates, Inc. (United States), Hygieia Biological Laboratories (United States), Colorado Serum Company (United States), Arko Laboratories, Ltd. (United States) and Intervacc AB (Sweden), to name a few.
North America is dominating the Pet Vaccine Market.

Know More About Global Pet Vaccine Market Report?

Have a Query? Click Here

Other Related Reports

Typhoid Vaccine Comprehensive Study by Type (Oral, Injection), Application (Hospital, Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies, Others) Players and Region - Global M...
$ 3500
Clostridium Difficile Treatment Comprehensive Study by Type (Narrow Spectrum Antibiotics, Broad Spectrum Antibiotics), Route of Administration (Oral, Intravenous / Parenteral), Distribution Channel (...
$ 3750
Clinical Trial Packaging Comprehensive Study by Packaging (Syringes, Vials & Ampoules, Bottles, Bags & Pouches, Tubes, Sachets, Kits or Packs, Others), End-User (Research Laboratories, Clinical Resea...
$ 3500
Omeprazole Comprehensive Study by Type (Capsule, Powder, Tablet, Suspension), Application (Gastroesophageal Reflux Disease (GERD), Barrett's Oesophagus, Duodenal Ulcer, Erosive Esophagitis, Hiatal He...
$ 3750
Primary Biliary Cirrhosis Drug Comprehensive Study by Type (Budesonide, FFP-104, GSK-2330672, MBX-8025, NGM-282, Others), Application (Clinic, Hospital, Others), Tests (Computed Tomography (CT), Ultr...
$ 3450
Cosmeceuticals Comprehensive Study by Type (Cleansing Agents, Mineral Oils, Herbal extract, Surfactants, Emollients, Enzymes, Others), Application (Skin Care, Hair Care, Oral Care, Eye Care, Others),...
$ 3650